Rating History for ISIS Pharmaceuticals (ISIS) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for ISIS
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/5/2015 N/A Upgrade Overweight
(Neutral)		 80.00
(64.00)		 53.01
(57.56)		 8.58% Details